| abstract |
The present invention relates to certain compounds of formula (Ia) and pharmaceutical compositions thereof that modulate the activity of 5-HT 2A serotonin receptors. The compound and pharmaceutical composition thereof include platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, clot formation, asthma or symptoms thereof, excitement or symptoms thereof, Behavioral disorder, drug-induced psychosis, excitatory psychosis, Gild-La-Tulette syndrome, mania, organic psychosis or unspecified psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, unspecified integration It is directed to methods useful in the treatment of ataxia and related diseases, as well as sleep disorders, sleep disorders, diabetes-related diseases, progressive multifocal leukoencephalopathy and the like. The invention also relates to methods for the treatment of 5-HT 2A serotonin receptor related disorders in combination with other drugs administered individually or together. |